We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

1 hedge funds and large institutions have $112M invested in NxStage Medical Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 171 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% less funds holding in top 10

Funds holding in top 10: 11 → 1 (-10)

93% less capital invested

Capital invested by funds: $1.73B → $112M (-$1.62B)

99% less funds holding

Funds holding: 172 → 1 (-171)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 171

Holders
1
Holders Change
-171
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-90.91%
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
171
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$176M
2
BlackRock
BlackRock
New York
-$155M
3
AA
AQR Arbitrage
Connecticut
-$105M
4
MF
Magnetar Financial
Illinois
-$84.9M
5
AAM
Alpine Associates Management
Florida
-$69.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
TAL
1
TIG Advisors LLC
New York
$112M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$176M -6,148,544 Closed
BlackRock
3
BlackRock
New York
– -$155M -5,424,200 Closed
AA
4
AQR Arbitrage
Connecticut
– -$105M -3,684,861 Closed
MF
5
Magnetar Financial
Illinois
– -$84.9M -2,967,320 Closed
AAM
6
Alpine Associates Management
Florida
– -$69.6M -2,433,167 Closed
WCMNY
7
Westchester Capital Management (New York)
New York
– -$64.4M -2,250,824 Closed
Millennium Management
8
Millennium Management
New York
– -$51.3M -1,792,232 Closed
Citadel Advisors
9
Citadel Advisors
Florida
– -$47.6M -1,662,607 Closed
State Street
10
State Street
Massachusetts
– -$45M -1,572,264 Closed
Marshall Wace
11
Marshall Wace
United Kingdom
– -$39.9M -1,393,302 Closed
UOC
12
UBS O'Connor
Illinois
– -$35.6M -1,244,006 Closed
JP Morgan Chase
13
JP Morgan Chase
New York
– -$35.1M -1,225,737 Closed
Citigroup
14
Citigroup
New York
– -$32.7M -1,142,599 Closed
MP
15
Manikay Partners
New York
– -$32.2M -1,125,200 Closed
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
– -$29.9M -1,045,899 Closed
UBS Group
17
UBS Group
Switzerland
– -$25.6M -893,856 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$24.2M -846,876 Closed
Northern Trust
19
Northern Trust
Illinois
– -$24.1M -842,282 Closed
Geode Capital Management
20
Geode Capital Management
Massachusetts
– -$23.8M -830,123 Closed
Norges Bank
21
Norges Bank
Norway
– -$22.9M -800,173 Closed
OAM
22
Oxford Asset Management
United Kingdom
– -$22.8M -797,440 Closed
PAMU
23
Pictet Asset Management (UK)
United Kingdom
– -$22.6K -788,232 Closed
GL
24
Governors Lane
New York
– -$22.5M -787,030 Closed
Flossbach Von Storch
25
Flossbach Von Storch
Germany
– -$20.2M -705,000 Closed
1
2 3 4 5

NXTM Hedge Fund Activity: Q1 2019 in Review

1 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2019, worth a combined $112M — down 93% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 171 funds closed out of NXTM and 0 opened new positions — a net loss of 171 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $176M sold.

  • 1 institutional investor held NxStage Medical Inc. (NXTM) as of Q1 2019, down from 172 in Q4 2018.
  • Funds reported $112M of NxStage Medical Inc. stock for Q1 2019, down 93% quarter-over-quarter.
  • 0 funds opened new NxStage Medical Inc. positions in Q1 2019 and 171 closed out, a net change of -171 holders.
  • The largest NxStage Medical Inc. seller in Q1 2019 was Vanguard Group, an estimated $176M sold.

Based on aggregated 13F filings for Q1 2019.